<DOC>
	<DOCNO>NCT00386191</DOCNO>
	<brief_summary>The primary objective compare safety clopidogrel 50mg 75mg cerebral infarction respect incidence bleed adverse event .</brief_summary>
	<brief_title>Safety Efficacy Clopidogrel Cerebral Infarction Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Patients episode cerebral infarction ( exclude cardiogenic cerebral thromboembolism ) occur least 8 day prior randomization clinical course randomization welldocumented Patients cerebral infarct confirm Computed Tomography Magnetic Resonance Image Body weight : &gt; 50 kg Patients cardiogenic cerebral thromboembolism disease could precipitate cardiogenic cerebral thromboembolism , atrial fibrillation valvular hear disease ( include valve replacement ) Patients Transient Ischemic Attack occur last episode cerebral infarction Patients serious impairment would hinder detection new ischemic event Patients bleed diathesis , coagulopathy , hemorrhagic disease Patients history intracranial hemorrhage Patients diabetic retinopathy Hypertensive patient persistent increase blood pressure .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Ischemic cerebrovascular disease</keyword>
</DOC>